COLOMBO NICOLETTA

De Vitis, L., Schivardi, G., Gaeta, A., Caruso, G., Rosanu, M., Ribero, L., et al. (2025). External validation of the Annual Recurrence Risk Model (ARRM) for tailored surveillance strategy in patients with cervical cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(6 (June 2025)) [10.1016/j.ijgc.2025.101756]. Detail

Valenza, C., Mongillo, M., Visconti, M., Katrini, J., Trapani, D., Boldrini, L., et al. (2025). Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study. GYNECOLOGIC ONCOLOGY, 194(March 2025), 11-17 [10.1016/j.ygyno.2025.01.014]. Detail

Oza, A., Lisyanskaya, A., Fedenko, A., De Melo, A., Shparyk, Y., Rakhmatullina, I., et al. (2025). Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial. THE LANCET ONCOLOGY, 26(2), 249-264 [10.1016/S1470-2045(24)00674-0]. Detail

De Vitis, L., Schivardi, G., Delfrati, S., Biffi, B., Viscardi, A., Rosanu, M., et al. (2025). The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(1) [10.1016/j.ijgc.2024.100024]. Detail

Caruso, G., Kumar, A., Langstraat, C., Mcgree, M., Fought, A., Harrington, S., et al. (2025). Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer. GYNECOLOGIC ONCOLOGY, 195(April 2025), 106-114 [10.1016/j.ygyno.2025.03.016]. Detail